CVS CVS Health Corp

$77.81

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

CVS Health's upcoming earnings report on October 29th is poised to capture attention, particularly as the company navigates the evolving healthcare landscape with a market cap of over $104 billion. Analysts are closely watching CVS's performance, especially given the EPS estimate of $1.37 and a revenue forecast of $98.87 billion. The whisper number, however, suggests a more optimistic EPS of $1.57, indicating that market insiders may expect stronger-than-anticipated results. This optimism could be fueled by CVS's strategic initiatives in expanding its healthcare services and digital health solutions, which have been pivotal in driving growth and enhancing customer engagement. As CVS continues to integrate its pharmacy and health services, investors will be keen to see how these efforts translate into financial performance, particularly in light of the competitive pressures within the healthcare sector. The upcoming earnings release will thus be a critical indicator of CVS Health's ability to sustain its growth trajectory and meet or exceed market expectations.

Updated On 11/17/2025

About CVS Health Corp

CVS Health (previously CVS Corporation and CVS Caremark Corporation) is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; Aetna, a health insurance provider, among many other brands. The company's headquarters is in Woonsocket, Rhode Island.

Website: https://www.cvshealth.com

Sector
TRADE & SERVICES
Industry
RETAIL-DRUG STORES AND PROPRIETARY STORES
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
64803
Address
ONE CVS DR., WOONSOCKET, RI, US
Valuation
Market Cap
$84.95B
P/E Ratio
18.39
PEG Ratio
0.70
Price to Book
1.12
Performance
EPS
$3.66
Dividend Yield
3.95%
Profit Margin
1.25%
ROE
6.02%
Technicals
50D MA
$65.40
200D MA
$58.69
52W High
$71.45
52W Low
$43.01
Fundamentals
Shares Outstanding
1B
Target Price
$75.97
Beta
0.57

CVS EPS Estimates vs Actual

Estimated
Actual

CVS News & Sentiment

Nov 17, 2025 • Benzinga NEUTRAL
Novo Nordisk Leans Into Affordability Amid Rising Competition - Novo Nordisk ( NYSE:NVO )
Novo Nordisk A/S ( NYSE:NVO ) announced on Monday that Wegovy ( semaglutide ) injection 0.25 mg and 0.5 mg and Ozempic are now available at a limited-time price of $199 per month to new self-pay patients between now and March 31, 2026.
Nov 17, 2025 • Zacks Commentary BULLISH
Is Teladoc Health Accelerating Growth Through Global Expansion?
TDOC accelerates global growth as expanding international operations and rising overseas revenues bolster its profitability outlook.
Nov 17, 2025 • Zacks Commentary SOMEWHAT-BULLISH
NVO Down 10% in 3 Months: Is This an Indication to Sell the Stock?
Novo Nordisk stock falls 10% in three months as guidance cuts, GLP-1 rivalry and looming U.S. price resets cloud growth and elevate execution risks.
Nov 17, 2025 • Zacks Commentary SOMEWHAT-BULLISH
CVS Health Posts Strong Q3 Earnings: How to Play the Stock Now?
CVS posts record Q3 revenues and a sharp EPS jump, lifting its 2025 outlook, while momentum builds across Aetna, Health Services and Pharmacy.
Nov 15, 2025 • Motley Fool SOMEWHAT-BULLISH
Hedge Fund Sells $25.6 Million in Paramount Group Stock as Rithm's $1.6 Billion Deal Looms
A surprising office-sector exit by a steady fund may reveal more about opportunity cost than pessimism.
Nov 14, 2025 • Motley Fool SOMEWHAT-BULLISH
Edible Garden ( EDBL ) Q3 2025 Earnings Transcript
Image source: The Motley Fool.Friday, November 14, 2025 at 8 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Sentiment Snapshot

Average Sentiment Score:

0.334
50 articles with scored sentiment

Overall Sentiment:

Bullish

CVS Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Pre market)
0.35 Surprise
  • Reported EPS: $1.81
  • Estimate: $1.46
  • Whisper:
  • Surprise %: 24.0%
May 01, 2025
Mar 31, 2025 (Pre market)
0.58 Surprise
  • Reported EPS: $2.25
  • Estimate: $1.67
  • Whisper:
  • Surprise %: 34.7%
Feb 12, 2025
Dec 31, 2024 (Pre market)
0.27 Surprise
  • Reported EPS: $1.19
  • Estimate: $0.92
  • Whisper:
  • Surprise %: 29.4%
Nov 06, 2024
Sep 30, 2024 (Pre market)
-0.37 Surprise
  • Reported EPS: $1.09
  • Estimate: $1.46
  • Whisper:
  • Surprise %: -25.3%
Aug 07, 2024
Jun 30, 2024 (Pre market)
0.1 Surprise
  • Reported EPS: $1.83
  • Estimate: $1.73
  • Whisper:
  • Surprise %: 5.8%
May 01, 2024
Mar 31, 2024 (Pre market)
-0.39 Surprise
  • Reported EPS: $1.31
  • Estimate: $1.70
  • Whisper:
  • Surprise %: -22.9%
Feb 07, 2024
Dec 31, 2023 (Pre market)
0.13 Surprise
  • Reported EPS: $2.12
  • Estimate: $1.99
  • Whisper:
  • Surprise %: 6.5%
Nov 01, 2023
Sep 30, 2023 (Pre market)
0.08 Surprise
  • Reported EPS: $2.21
  • Estimate: $2.13
  • Whisper:
  • Surprise %: 3.8%
Aug 02, 2023
Jun 30, 2023 (Pre market)
0.1 Surprise
  • Reported EPS: $2.21
  • Estimate: $2.11
  • Whisper:
  • Surprise %: 4.7%

Financials